IRIS
LLEO DE NALDA, Ana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.942
AS - Asia 4.723
EU - Europa 1.572
SA - Sud America 953
AF - Africa 261
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 14.469
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.798
SG - Singapore 2.824
CN - Cina 816
BR - Brasile 790
VN - Vietnam 445
FI - Finlandia 286
IT - Italia 279
IE - Irlanda 208
DE - Germania 170
NG - Nigeria 170
FR - Francia 126
HK - Hong Kong 120
GB - Regno Unito 109
IN - India 95
SE - Svezia 94
NL - Olanda 77
CA - Canada 70
AR - Argentina 63
BD - Bangladesh 53
AE - Emirati Arabi Uniti 51
TR - Turchia 50
IQ - Iraq 43
MX - Messico 42
RU - Federazione Russa 42
ID - Indonesia 30
BE - Belgio 28
PK - Pakistan 28
ZA - Sudafrica 27
EC - Ecuador 24
PL - Polonia 21
UA - Ucraina 21
IL - Israele 20
MK - Macedonia 20
ES - Italia 18
CL - Cile 17
JP - Giappone 17
PH - Filippine 17
CZ - Repubblica Ceca 16
MA - Marocco 15
CO - Colombia 14
VE - Venezuela 14
SA - Arabia Saudita 13
UZ - Uzbekistan 13
PY - Paraguay 12
ET - Etiopia 11
JO - Giordania 10
KZ - Kazakistan 10
MY - Malesia 10
NP - Nepal 10
AU - Australia 9
AT - Austria 8
DZ - Algeria 8
KE - Kenya 8
RO - Romania 8
DO - Repubblica Dominicana 7
EG - Egitto 7
KR - Corea 7
PE - Perù 7
UY - Uruguay 7
AZ - Azerbaigian 6
GR - Grecia 6
OM - Oman 6
RS - Serbia 6
TN - Tunisia 6
BB - Barbados 5
IR - Iran 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
AL - Albania 4
LT - Lituania 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CH - Svizzera 3
EU - Europa 3
KG - Kirghizistan 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
AM - Armenia 2
CR - Costa Rica 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SN - Senegal 2
AO - Angola 1
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
Totale 14.454
Salva come PNG Salva come JPEG
Città #
Singapore 1.339
Chandler 957
Wilmington 826
Ashburn 508
Dallas 440
The Dalles 412
Shanghai 355
San Jose 332
San Mateo 313
Helsinki 284
Ann Arbor 266
New York 215
Dublin 208
Beijing 204
Boardman 189
Benin City 167
Lawrence 155
Princeton 155
Ho Chi Minh City 141
Leawood 141
Hanoi 122
Hong Kong 114
Milan 100
Paris 95
Fairfield 70
São Paulo 70
Woodbridge 70
Amsterdam 57
Los Angeles 57
London 50
Seattle 42
Toronto 36
Phoenix 30
Brussels 28
Naples 27
Da Nang 26
Orem 25
Santa Clara 25
Chennai 24
Falkenstein 24
Baghdad 22
Council Bluffs 22
Pune 18
San Diego 18
Brasília 17
Munich 17
Redwood City 17
Rio de Janeiro 17
Abbiategrasso 16
Assago 16
Frankfurt am Main 16
Haiphong 16
Rome 16
Stockholm 16
Brooklyn 15
Dhaka 15
Kocaeli 15
Montreal 15
Tokyo 15
Warsaw 15
Belo Horizonte 14
Johannesburg 14
Boston 13
Norwalk 13
Tashkent 13
Campinas 12
Columbus 12
Porto Alegre 12
Atlanta 11
Brno 11
Guarulhos 11
Guayaquil 11
Mexico City 11
Addis Ababa 10
Manchester 10
San Francisco 10
Amman 9
Buenos Aires 9
Istanbul 9
Mauá 9
Skopje 9
Ankara 8
Biên Hòa 8
Charlotte 8
Chicago 8
Ninh Bình 8
Salvador 8
City of London 7
Curitiba 7
Denver 7
Duque de Caxias 7
Jakarta 7
Kuala Lumpur 7
Nairobi 7
Nova Iguaçu 7
Thái Nguyên 7
Buffalo 6
Cairo 6
Clearwater 6
Cuiabá 6
Totale 9.401
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? 153
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 133
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 131
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 128
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 125
B cell depletion therapy exacerbates murine primary biliary cirrhosis 110
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 109
Lights and Shadows on Fibrates as Second-Line Therapy of Primary Biliary Cholangitis 108
Apotopes and the biliary specificity of primary biliary cirrhosis 108
COVID-19 and liver cancer clinical trials: not everything is lost 107
Innate Immunity and Primary Biliary Cirrhosis 106
Genetic associations in Italian primary sclerosing cholangitis : heterogeneity across Europe defines a critical role for HLA-C 104
Autophagy: highlighting a novel player in the autoimmunity scenario 104
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 103
Interferon α and its contribution to autoimmunity 101
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis 100
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 99
The consequences of apoptosis in autoimmunity 98
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis 98
Is autoimmunity a matter of sex? 97
Comparative analysis of portal cell infiltrates in AMA positive versus AMA negative PBC 97
Prevalence and clinical significance of intrahepatic cholangiocellular carcinoma with radiological enhancement pattern mimicking hepatocellular carcinoma 97
The X chromosome and immune associated genes 96
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 95
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis 94
Clinical Outcomes in the Second versus First Pandemic Wave in Italy: Impact of Hospital Changes and Reorganization 94
Definition of human autoimmunity - autoantibodies versus autoimmune disease 92
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 92
Advances in pharmacotherapy for primary biliary cirrhosis 92
Apotopes and innate immune system: Novel players in the primary biliary cirrhosis scenario 92
High mortality in COVID-19 patients with mild respiratory disease 92
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis 91
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 91
HLA Class II antigens associated with lupus nephritis in Italian SLE patients 90
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review 90
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 90
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 90
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine 89
Hepatitis C virus eradication with DAA and liver cancer recurrence: is the best the enemy of the good? 89
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature 88
Benign liver tumors: Diagnostics and treatment 88
Autoimmunity and Turner's syndrome 88
Safety of vedolizumab in liver transplant recipients: A systematic review 88
Mapping the human genetic architecture of COVID-19 88
The risk of Liver Cancer in Autoimmune Liver Diseases 87
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals 86
Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase 86
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 85
Primary biliary cholangitis: a comprehensive overview. 84
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 84
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis 84
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis 83
Levels of Alkaline Phosphatase and Bilirubin are Surrogate Endpoints of Outcomes of Patients with Primary Biliary Cirrhosis - an International Follow-up Study 83
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 83
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C 83
Y chromosome loss in male patients with primary biliary cirrhosis 82
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine 82
Changes in the Epidemiology of Primary Biliary Cholangitis 82
Making sense of Autoantibodies in Cholestatic Liver Diseases 81
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 81
Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis 81
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 80
Etiopathogenesis of primary biliary cirrhosis 79
The X-Factor in Primary Biliary Cirrhosis: Monosomy X and Xenobiotics 78
Letter to the Editor: might denosumab fit in PBC treatment? 78
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference 78
Liver Injury Induced by Immune Checkpoint Inhibitors: An Affordable Risk of Cancer Therapy? 78
Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes 78
Role of liver biopsy in hepatocellular carcinoma 78
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 77
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 77
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 77
Antimitochondrial Antibodies: from Bench to Bedside 77
Mediterranean diet and NAFLD: What we know and questions that still need to be answered 76
Evolving trends in female to male incidence and male mortality of primary biliary cholangitis 76
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Interpreting serological tests in diagnosing autoimmune liver diseases 75
The immunological potential of galectin-1 and 3 75
Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications 75
Geoepidemiology, Genetic and Environmental Risk Factors for PBC 75
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls 75
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 74
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells 74
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 74
Genetics and epigenetics of primary biliary cirrhosis 74
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 74
Primary biliary cholangitis 74
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 74
Modulation of CD4(+) T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis 73
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 73
Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment 73
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario 72
Coronary flow reserve is an innovative tool for the early detection of cardiovascular dysfunction in primary biliary cholangitis patients. 72
Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases 71
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 71
Postsustained Virological Response Management in Hepatitis C Patients 70
Common Variable Immunodeficiency and Liver Involvement 70
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis 70
Totale 8.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 0 0 0 177 5 163
2021/2022833 30 10 15 178 8 11 22 109 89 92 201 68
2022/20232.567 349 128 244 319 234 221 13 187 459 205 162 46
2023/20241.616 120 146 347 73 46 220 118 99 34 32 133 248
2024/20252.514 55 51 22 60 61 317 224 254 349 566 275 280
2025/20265.606 900 382 499 592 196 255 1.773 323 386 300 0 0
Totale 14.676